1. Home
  2. MLAB vs BDN Comparison

MLAB vs BDN Comparison

Compare MLAB & BDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mesa Laboratories Inc.

MLAB

Mesa Laboratories Inc.

HOLD

Current Price

$105.89

Market Cap

461.9M

Sector

Industrials

ML Signal

HOLD

Logo Brandywine Realty Trust

BDN

Brandywine Realty Trust

HOLD

Current Price

$3.02

Market Cap

535.0M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
MLAB
BDN
Founded
1982
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Real Estate Investment Trusts
Sector
Industrials
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
461.9M
535.0M
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
MLAB
BDN
Price
$105.89
$3.02
Analyst Decision
Hold
Hold
Analyst Count
1
4
Target Price
$94.00
$3.50
AVG Volume (30 Days)
85.7K
2.1M
Earning Date
05-27-2026
04-22-2026
Dividend Yield
0.67%
10.67%
EPS Growth
99.24
9.65
EPS
1.95
N/A
Revenue
N/A
$484,454,000.00
Revenue This Year
$6.07
$12.96
Revenue Next Year
$5.41
N/A
P/E Ratio
$53.24
N/A
Revenue Growth
N/A
N/A
52 Week Low
$59.63
$2.47
52 Week High
$128.55
$4.63

Technical Indicators

Market Signals
Indicator
MLAB
BDN
Relative Strength Index (RSI) 65.71 57.13
Support Level $69.73 $2.91
Resistance Level $106.28 $3.14
Average True Range (ATR) 4.43 0.11
MACD 0.17 0.01
Stochastic Oscillator 92.48 71.67

Price Performance

Historical Comparison
MLAB
BDN

About MLAB Mesa Laboratories Inc.

Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

About BDN Brandywine Realty Trust

Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.

Share on Social Networks: